Parkinson's disease is caused by the degeneration of neurons in the midbrain. The mechanisms leading to the loss of these neurons, however, are largely unknown. Recent research revealed that about ten per cent of cases are caused by defects in so-called Parkinson-associated genes.
Furthermore, mitochondria, the cellular powerhouses, seem to play a major role. New results from researchers at the LMU Munich under the lead of associate professor Dr. Konstanze Winklhofer and Professor Christian Haass connect both phenomena, showing that two Parkinson genes maintain the function of mitochondria. "Diseases like Parkinson's where at least some cases are unambiguously related to the dysfunction of specific genes offer a promising research opportunity," explains biochemist Dr. Konstanze Winklhofer "When we understand the function of these genes, we can learn a lot about the causes of the disease, its progress and possible new therapies." Professor Wolfgang Wurst and his group of the Institute for Developmental Genetics at the Helmholtz Center Munich also contributed to this work. (Journal of Biological Chemistry, 21 August, 2009)
Four million individuals are estimated to suffer from Parkinson's disease worldwide. This neurodegenerative disorder is characterized by rigid muscles, uncontrollable tremor and slowing – or even loss of – voluntary movements. It is caused by the death of nerve cells in a midbrain area called substantia nigra. These neurons secrete dopamine, a neurotransmitter involved in the control of movements. Thus, a loss of dopamine-producing neurons causes a dysbalance in the regulation of movements.
"Functionally impaired mitochondria have been recognized to trigger Parkinson's disease already in the early eighties," Dr. Konstanze Winklhofer says, an associate professor at the Adolf-Butenandt Institute of the Ludwig-Maximilians-Universität (LMU) in Munich. At this time it was discovered by accident that mitochondrial toxins can induce Parkinson's disease. The relevance of mitochondria to the loss of neurons seems plausible – after all, mitochondria supply the cells with energy in form of adenosine triphosphate and play a substantial role in the regulation of cell death.
The scientists' results now combine both observations on a genetic basis. They found that the Parkinson-associated genes PINK1 and Parkin functionally interact to maintain mitochondrial function. Loss of Parkin or PINK1 function impairs the morphology and activity of mitochondria, which then produce less adenosine triphosphate. "Our results also confirm the high neuroprotective potential of Parkin", Winklhofer says. "We observed that Parkin can compensate a loss of PINK1 function, but not the other way round". Winklhofer and her colleagues have shown earlier that Parkin can protect neurons under various stress conditions.
Until today, there is no possibility to prevent or cure Parkinson's disease. All pharmacological approaches are merely symptomatic and aim at replacing the neurotransmitter dopamine. Insight into the function of Parkinson-associated genes can help to identify new targets for therapeutic strategies in order to prevent or halt the loss of dopamine-producing neurons. So far, six Parkinson-associated genes are known whose functions remain to be elucidated in detail. In the case of Parkin and PINK1 scientists have made significant steps forward and now aim at uncovering the molecular mechanisms of their functions.
Journal of Biological Chemistry, 21. August 2009. Vol. 284, Issue 34, 22938-22951Contact:
Dr. Konstanze F. Winklhofer | EurekAlert!
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
05.12.2016 | Earth Sciences
05.12.2016 | Physics and Astronomy
05.12.2016 | Life Sciences